Industry: Attending Companies Include - 8th RAS-Targeted Drug Development Summit

Register by Friday, June 12 & Save up to $800

Day

Hour

Minute

Second

Game‑changing pan‑RAS data from RevMed drives RAS into its next phase
Incyte, BMS & Amgen tackle resistance with new ASCO data

Nothing Found

It seems we can't find what you're looking for. Perhaps searching can help.